SCHEMBL6168093

SCHEMBL6168093

CCn1c(=O)c2ccc(Cl)cc2c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.59
NPY5R Q15761 4/20 0.55
ALDH1A1 P00352 2/20 0.51
PGR P06401 2/20 0.51
RORA P35398 1/20 0.51
RORC P51449 1/20 0.51
RORB Q92753 1/20 0.51
MAPT P10636 3/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NPC1 O15118 1/20 0.51
MITF O75030 1/20 0.51
AGTR1 P30556 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11720741 0.84 PGR (0.69) NPY5RALDH1A1PGRRORARORC
SCHEMBL29643271 0.82 MAPT (0.65) ALDH1A1MAPTLMNAHTTCYP1A2
SCHEMBL1921288 0.82 MAPT (0.65) ALDH1A1MAPTLMNAHTTCYP1A2
SCHEMBL14037008 0.82 MAPT (0.57) ALDH1A1MAPTLMNAHTTCYP1A2
SCHEMBL6169717 0.82 KDM4E (0.69) NPY5RALDH1A1PGRRORARORC
SCHEMBL8086738 0.80 ALDH1A1 (0.72) ALDH1A1MAPTLMNAHTTCYP1A2
SCHEMBL11391828 0.80 ALDH1A1 (0.72) ALDH1A1MAPTLMNAHTTCYP1A2
SCHEMBL6170278 0.77 MAPT (0.75) NPY5RALDH1A1MAPTLMNAHTT
SCHEMBL24182603 0.77 MAPK1 (0.53) ALDH1A1PGRLMNACYP1A2CYP3A4
Chlorobenzene SCHEMBL28571942 0.77 ALDH1A1 (0.60) ALDH1A1PGRMAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6958347-B2 Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists PFIZER INC. (US) 2005-10-25 US disclosed
EP-1578728-A1 5-AMINOPHENANTHRIDINE DERIVATIVES AS NPY-5 ANTAGONISTS Pfizer Products Inc. (US) 2005-09-28 EP disclosed
WO-2004054981-A1 5-AMINOPHENANTHRIDINE DERIVATIVES AS NPY-5 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2004-07-01 WO disclosed
US-20040122038-A1 NPY-5 antagonists PFIZER INC 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122038-A1 NPY-5 antagonists NPY5R, NPY1R, NPY2R DPP4 1219/4885NPY5R 1/4885ALDH1A1 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.